Dr. Martens plc (DRMTY) Stock Price & Analysis
Dr. Martens plc (DRMTY) — price $1.85 (0.00%), as of the Oct 5, 2026 trading session; market cap $885M.
Educational signal · not a buy or sell recommendation · How to read this
Dr. Martens plc · DRMTY
Dr. Martens plc designs, develops, and distributes footwear globally, operating under the iconic Dr. Martens brand. The company's product range includes originals, fusion styles, kids' footwear, casual options, and accessories.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $1.85 | |
| Change on the day | 0.00% | |
| 52-week range | $1.43 – $2.57 | |
| Market capitalisation | $885M | |
| Price / earnings (trailing) | 26.75 | |
| Shares traded on the day | 150 |
Price & events
Other perspectives
Council score for Dr. Martens (DRMTY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
9-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 11, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 6, 2026, except a card that shows its own read date.
Watch the DRMTY film — every key number, told as a short cinematic story
~2 min · open the film
What is Dr. Martens (DRMTY), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Dr. Martens plc (DRMTY) is the company analyzed here. It employs 2,377 people and is led by Ije Nwokorie. In Q4 FY2026 it reported revenue of $594M and net income of $45M. The market values it at $885M.
What do the latest results show for Dr. Martens (DRMTY)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of $594M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | $594M | $45M | $0.09 (diluted) |
| Q2 FY2026 | $425M | -$13M | -$0.03 (diluted) |
| Q4 FY2025 | $612M | $33M | $0.07 (diluted) |
| Q2 FY2025 | $429M | -$27M | -$0.06 (diluted) |
What are the financial strengths and risks for Dr. Martens (DRMTY)?
Short answer
The distress and quality screens read Altman Z 6.14 · Piotroski F 6. Trailing ratios: ROE 6.9% · ROA 2.7% · current ratio 2.61 · earnings yield 3.6% · free-cash-flow yield 17.6%.
Common Questions About DRMTY
These answers are editorial: 2 of these 8 answers are drawn from the DRMTY research dossier (written Mar 18, 2026 by gemini-2.0-flash); the other 6 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is DRMTY a good stock to buy?
Stock Expert AI does not rate DRMTY buy, sell or hold. Dr. Martens plc has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the DRMTY stock price today?
The last price recorded on this page for Dr. Martens plc (DRMTY) is $1.85, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Dr. Martens plc do?
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear globally. The company's product segments include originals, fusion, kids, and casual, as well as accessories. It operates under the Dr. Martens brand name, selling through owned retail stores, e-commerce platforms, and wholesale partners.
What are the main risks for DRMTY?
The main risks for DRMTY include fluctuations in consumer spending, intense competition from other footwear brands, and changes in fashion trends. A decline in consumer confidence or disposable income could negatively impact demand for Dr. Martens products.
What are the key factors to evaluate for DRMTY?
Evaluate DRMTY on fundamentals, analyst consensus, and risk factors. P/E: 26.75x. E-commerce Growth: The increasing popularity of online shopping presents a significant growth opportunity for Dr. Martens. Not financial advice.
How frequently does DRMTY data refresh on this page?
DRMTY's price is the last quote we recorded, from the Oct 5, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven DRMTY's recent stock price performance?
Dr. Martens plc (DRMTY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand recognition and heritage. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DRMTY overvalued or undervalued right now?
Dr. Martens plc (DRMTY) trades at 26.75x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (14 figures)
The 14 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 9 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $1.85 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T13:54:40.497Z. | |
px.change | Change on the day | 0.00% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $885M | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-05T13:54:38.686Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | $0.00 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 26.75 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 150 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q4 FY2026 | $594M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q4 FY2026 | $45M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q4 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed |
UNRECORDED — 5 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $1.43 – $2.57 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
id.employees | Employees | 2,377 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
id.ceo | Chief executive | Ije Nwokorie | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
fin.scores | Distress and quality screens | Altman Z 6.14 · Piotroski F 6 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-03 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 6.9% · ROA 2.7% · current ratio 2.61 · earnings yield 3.6% · free-cash-flow yield 17.6% | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.